Business Context and Reporting Period
This Form 8-K Current Report from Dynex Capital, Inc. (DX) covers events occurring on February 26, 2026. The filing primarily addresses significant changes in executive leadership, specifically the appointment of a new Chief Financial Officer (CFO) and the departure of the incumbent CFO.
Key Financial Metrics
The filing does not provide operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to executive compensation:
- Michael Sartori (New CFO) Equity Grants:
- Restricted Stock Units (RSUs): Valued at $350,000 at grant date.
- Performance Stock Units (PSUs): Valued at $1,200,000 at grant date.
- Robert S. Colligan (Outgoing CFO) Severance: Eligible for severance and benefits under an Employment Agreement dated July 19, 2024. Specific dollar amounts are not disclosed in this text.
Material Changes Versus Prior Period
The material change reported is a leadership transition within the finance function:
- Appointment: Michael Sartori was appointed CFO effective February 26, 2026. He previously served as Head of Capital Markets and Financial Planning and Analysis since October 2019 and Assistant Controller from August 2013 to October 2019.
- Departure: Robert S. Colligan ceased serving as CFO effective February 26, 2026. He will remain employed as a Special Advisor to the Co-CEOs through May 1, 2026, to assist with the transition.
Guidance, Outlook, and Risks
Management Commentary: The Board approved the transition to ensure continuity in capital strategy and financial performance. Mr. Sartori will report to the Co-CEOs.
Risks and Contingencies: The filing explicitly states that Mr. Colligan's departure is not the result of any disagreements regarding financial disclosures, accounting matters, operations, policies, or practices. No other risks or contingencies are detailed in this specific report.
Guidance: No financial guidance or outlook is provided in this filing.
Investor Verification Checklist
- Verify the specific terms and vesting conditions of the $1.55 million total equity grant to Michael Sartori in the full award agreements.
- Review the Employment Agreement filed as Exhibit 10.3 to the June 30, 2024, 10-Q to determine the exact severance value for Robert S. Colligan.
- Confirm the transition timeline and the specific responsibilities of the "Special Advisor" role for Mr. Colligan through May 1, 2026.
- Monitor subsequent filings for any impact on the company's capital structure or financial reporting processes following the leadership change.